Zealand Pharma
Stock
Stock
ISIN: DK0060257814
Ticker: ZEAL
DK0060257814
ZEAL
Price
Price
CHART BY
Frequently asked questions
What is Zealand Pharma's market capitalization?
The market capitalization of Zealand Pharma is $2.92B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Zealand Pharma's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Zealand Pharma is 7.08. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Zealand Pharma?
Zealand Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $5.94. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Zealand Pharma's stock?
Currently, 16 analysts cover Zealand Pharma's stock, with a consensus target price of $62.91. Analyst ratings provide insights into the stock's expected performance.
What is Zealand Pharma's revenue over the trailing twelve months?
Over the trailing twelve months, Zealand Pharma reported a revenue of $707.55M.
What is the EBITDA for Zealand Pharma?
Zealand Pharma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $363.30M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Zealand Pharma?
Zealand Pharma has a free cash flow of -$273.68M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Zealand Pharma have, and what sector and industry does it belong to?
Zealand Pharma employs approximately 481 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Zealand Pharma's shares?
The free float of Zealand Pharma is 61.23M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $2.92B
- EPS (TTM)
- $5.94
- Free Float
- 61.23M
- P/E ratio (TTM)
- 7.08
- Revenue (TTM)
- $707.55M
- EBITDA (TTM)
- $363.30M
- Free Cashflow (TTM)
- -$273.68M
Pricing
- 1D span
- $41.31$42.71
- 52W span
- $36.34$85.80
Analyst Ratings
The price target is $62.91 and the stock is covered by 16 analysts.
Buy
8
Hold
8
Sell
0
Information
Zealand Pharma A/S is a biotechnology company, which engages in the discovery, design, and development of peptide based medicines. Its products include Zegalogue and V-Go. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on April 1, 1997 and is headquartered in Soborg, Denmark.
- Employees
- 481
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- DK0060257814
- Primary Ticker
- ZEAL
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet